atenolol has been researched along with Thyrotoxicosis in 4 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Thyrotoxicosis: A hypermetabolic syndrome caused by excess THYROID HORMONES which may come from endogenous or exogenous sources. The endogenous source of hormone may be thyroid HYPERPLASIA; THYROID NEOPLASMS; or hormone-producing extrathyroidal tissue. Thyrotoxicosis is characterized by NERVOUSNESS; TACHYCARDIA; FATIGUE; WEIGHT LOSS; heat intolerance; and excessive SWEATING.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tachamo, N | 1 |
| Lohani, S | 1 |
| Nazir, S | 1 |
| Juliano, N | 1 |
| Masannat, Y | 1 |
| Gandhy, R | 1 |
| Olajide, O | 1 |
| Kheetan, R | 1 |
| Yaqub, A | 1 |
| Solomon, BL | 1 |
| Wartofsky, L | 1 |
| Burman, KD | 1 |
| Zefirova, GS | 1 |
| Makhneva, IM | 1 |
| Kochergina, II | 1 |
| Plevako, VA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Multi-center, Open Label, Randomised Parallel- Group Study to Compare the Efficacy of Cholestyramine Plus Standard Treatment Versus Prednisolone Plus Standard Treatment Versus Standard Treatment Alone in Treatment of Overt Hyperthyroidism[NCT03303053] | Phase 3 | 135 participants (Anticipated) | Interventional | 2017-05-11 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for atenolol and Thyrotoxicosis
| Article | Year |
|---|---|
Adjunctive cholestyramine therapy for thyrotoxicosis.
Topics: Adult; Atenolol; Chemotherapy, Adjuvant; Cholestyramine Resin; Double-Blind Method; Female; Graves D | 1993 |
3 other studies available for atenolol and Thyrotoxicosis
| Article | Year |
|---|---|
Paralysis that easily reverses: a case of thyrotoxic periodic paralysis.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Antithyroid Agents; Atenolol; Humans; Hypokalemia; Hy | 2017 |
Chorea associated with thyrotoxicosis due to toxic multinodular goiter.
Topics: Antithyroid Agents; Atenolol; Chorea; Dibenzothiazepines; Female; Goiter, Nodular; Humans; Hyperthyr | 2011 |
[An apathetic form of thyrotoxicosis].
Topics: Adrenergic beta-Antagonists; Antithyroid Agents; Atenolol; Chronic Disease; Diagnosis, Differential; | 1998 |